Colgate-Palmolive (CL) Projected to Release Quarterly Earnings on Friday

Colgate-Palmolive (NYSE:CL) is anticipated to issue its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect the company to post earnings of $0.9470 per share and revenue of $5.3563 billion for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the previous year, the company posted $0.91 EPS. The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Trading Up 1.0%

CL stock opened at $92.87 on Wednesday. The stock has a market cap of $74.32 billion, a price-to-earnings ratio of 36.14, a price-to-earnings-growth ratio of 4.84 and a beta of 0.33. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The company has a fifty day moving average price of $90.87 and a two-hundred day moving average price of $89.26. Colgate-Palmolive has a one year low of $74.54 and a one year high of $99.33.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s payout ratio is currently 82.49%.

Institutional Trading of Colgate-Palmolive

Several institutional investors and hedge funds have recently modified their holdings of CL. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the last quarter. Woodline Partners LP grew its stake in shares of Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. grew its position in shares of Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after buying an additional 245 shares during the last quarter. Nebula Research & Development LLC increased its position in Colgate-Palmolive by 165.5% during the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock valued at $939,000 after purchasing an additional 6,437 shares during the period. Finally, Sei Investments Co. boosted its stake in shares of Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after purchasing an additional 116,968 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on CL. Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the company a “buy” rating in a research note on Tuesday, April 21st. Bank of America dropped their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a report on Friday, April 10th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. UBS Group upped their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company a “buy” rating in a research note on Thursday, July 16th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $97.82.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.